NCT01939457View on ClinicalTrials.gov

400mcg Sublingual Misoprostol as First Line Treatment

NACompletedINTERVENTIONAL
Enrollment

641

Participants

Timeline

Start Date

September 30, 2011

Primary Completion Date

August 31, 2012

Study Completion Date

August 31, 2012

Conditions
Incomplete Abortion
Interventions
DRUG

Misoprostol

Trial Locations (1)

Unknown

Guediawaye Health Center, Guédiawaye

All Listed Sponsors
lead

Gynuity Health Projects

OTHER

NCT01939457 - 400mcg Sublingual Misoprostol as First Line Treatment | Biotech Hunter | Biotech Hunter